|
| | Issue Date | Title | Author(s) |
| 81 | Nov-2023 | FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review | Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal; Dokla, Eman |
| 82 | 2024 | FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives | Heba M. Hesham; Eman Z. Elrazaz; Deena S. Lasheen; Dalal A. Abou El Ella; Dokla, Eman |
| 83 | 2016 | Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Aziz, M.A. ; Serya, RAT; Lasheen, DS; Abouzid, Khaled ; Serya, Rabah |
| 84 | Feb-2021 | Green analysis of newly approved binary omeprazole/aspirin mixture in presence of aspirin impurity using ultra-high-performance liquid chromatography and thin-layer chromatography methods | Abdelaleem, Eglal A; Abou El Ella, Dalal ; Mahmoud, Alaa M; Abdelhamid, Nessreen S |
| 85 | 2022 | Hands-on synthetic approaches and biological activities of anthranilic acid derivatives: A mini-review | Nasr, Tamer; Aboshanab, Ahmed; Abouzid, Khaled ; Zaghary, Wafaa |
| 86 | 25-Oct-1996 | Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand | Khanolkar, A D; Abadji, V; Lin, S; Hill, W A; Taha, G; Abouzid, Khaled ; Meng, Z; Fan, P; Makriyannis, A |
| 87 | 1-Nov-2024 | Hibiscus schizopetalus boosts wound healing via restoring redox balance and hindering inflammatory responses in rats: Insights on metabolome profiling and molecular docking | Gamal El-Din, Mariam I.; Mantawy, Eman M.; Said, Riham S.; Fahmy, Nouran M.; Fayez, Shaimaa; Shahin, Mai I. ; Nasr, Maha ; Elissawy, Ahmed M. |
| 88 | 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 89 | 13-Nov-2018 | Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis | Ge, Xin; Pan, Min-Hong; Wang, Lin; Li, Wei; Jiang, Chengfei; He, Jun; Abouzid, Khaled ; Liu, Ling-Zhi; Shi, Zhumei; Jiang, Bing-Hua |
| 90 | Mar-2022 | Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment | Elgiushy, Hossam R; Mohamed, Sameh H; Sawaf, Hussein; Hassan, Zeinab; Abou-Taleb, Nageh A; El-Labbad, Eman M; Hassan, Ashraf S; Abouzid, Khaled A M; Abouzid, Khaled ; Ali Taha, Heba |
| 91 | Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 92 | 8-Mar-2022 | Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation | Mansour, Mai A; Oraby, Mamdouh A; Muhammad, Zeinab A; Lasheen, Deena ; Gaber, Hatem M; Khaled A M Abouzid |
| 93 | 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| 94 | 2018 | Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study | Ewida, Menna A; Abou El Ella, Dalal ; Lasheen, Deena S. ; Ewida, Heba A; El-Gazzar, Yomna I; El-Subbagh, Hussein I |
| 95 | Jul-2013 | In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2 | Ahmed, Marawan; Sadek, Maiada M; Abouzid, Khaled ; Wang, Feng; Serya, Rabah |
| 96 | 4-May-2016 | Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives | Eldehna, Wagdy M; Abou-Seri, Sahar M; El Kerdawy, Ahmed M; Ayyad, Rezk R; Hamdy, Abdallah M; Ghabbour, Hazem A; Ali, Mamdouh M; Abou El Ella, Dalal |
| 97 | 1-Dec-2021 | Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer | Dokla, Eman ; Abdel-Aziz, Amal Kamal ; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 98 | 15-Jul-2015 | Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking | Eldehna, Wagdy M; Fares, Mohamed; Ibrahim, Hany S; Aly, Mohamed H; Zada, Suher; Ali, Mamdouh M; Abou-Seri, Sahar M; Abdel-Aziz, Hatem A; Abou El Ella, Dalal |
| 99 | 1-Jun-2022 | Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells | Chu, Po Chen; Dokla, Eman ; Hu, Jing Lan; Weng, Jing Ru |
| 100 | 2022 | Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno[2,3-d]pyrimidine-based EGFR inhibitors | Milik, SN; Abdel-Aziz, AK; El-Hendawy, MM; El-Gogary, RI; Saadeldin, MK; Minucci, S; Klein, CD; Abouzid, Khaled |
